UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 215

Sortiert nach

Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry

Haematologica (Roma), 2014-05, Vol.99 (5), p.922

2014

Volltextzugriff (PDF)

Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?

Vox sanguinis, 2010-07, Vol.99 (1), p.1-15

2010

Volltextzugriff (PDF)

Mesenchymal stem cells for clinical application

Vox sanguinis, 2010-02, Vol.98 (2), p.93-107

2010

Volltextzugriff (PDF)

Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups

Haematologica (Roma), 2012-08, Vol.97 (8), p.1142-1148

2012

Volltextzugriff (PDF)

Superior physical and mental health of healthy volunteers before and five years after mobilized stem cell donation

Journal of translational medicine, 2022-03, Vol.20 (1), p.121-121, Article 121

2022

Volltextzugriff (PDF)

Changing prognosis in paroxysmal nocturnal haemoglobinuria disease subcategories: an analysis of the International PNH Registry

Internal medicine journal, 2016-09, Vol.46 (9), p.1044-1053

2016

Volltextzugriff (PDF)

Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation

Haematologica (Roma), 2014-10, Vol.99 (10), p.1574

2014

Volltextzugriff (PDF)

Aplastic anemia

Deutsche medizinische Wochenschrift (1946), 2014-12, Vol.139 (49), p.2503

2014

Volltextzugriff (PDF)

Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors

Haematologica (Roma), 2010-12, Vol.95 (12), p.2119-2125

2010

Volltextzugriff (PDF)

Resequencing of four novel alleles with nanopore technology

HLA, 2018-10, Vol.92 (4), p.233-234

2018

Volltextzugriff (PDF)

Supportive care in severe and very severe aplastic anemia

Bone marrow transplantation (Basingstoke), 2013-02, Vol.48 (2), p.168-173

2013

Volltextzugriff (PDF)

How much blood is needed?

Vox sanguinis, 2011-01, Vol.100 (1), p.10-21

2011

Volltextzugriff (PDF)

ATP promotes immunosuppressive MSCs inhibiting lymphocyte proliferation and expressing indoleamine dioxygenase

European journal of cancer (1990), 2017-02, Vol.72, p.S98-S98

2017

Volltextzugriff (PDF)

GMP-adapted overexpression of CXCR4 in human mesenchymal stem cells for cardiac repair

International journal of cardiology, 2013-09, Vol.167 (5), p.2073-2081

2013

Volltextzugriff (PDF)

International Forum on GMP‐grade human platelet lysate for cell propagation: summary

Vox sanguinis, 2018-01, Vol.113 (1), p.80-87

2018

Volltextzugriff (PDF)

Alternative immunosuppression in patients failing immunosuppression with ATG who are not transplant candidates: Campath (Alemtuzumab)

Bone marrow transplantation (Basingstoke), 2013-02, Vol.48 (2), p.186-190

2013

Volltextzugriff (PDF)

Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload

Annals of hematology, 2013-01, Vol.92 (2), p.191-198

2013

Volltextzugriff (PDF)

Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia

Bone marrow transplantation (Basingstoke), 2006-04, Vol.37 (7), p.641-649

2006

Volltextzugriff (PDF)

Recent improvement in outcome of unrelated donor transplantation for aplastic anemia

Bone marrow transplantation (Basingstoke), 2008-01, Vol.41 (1), p.45-50

2008

Volltextzugriff (PDF)

Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapy

Leukemia, 2014-08, Vol.28 (8), p.1759-1762

2014

Volltextzugriff (PDF)

Iron-loaded PLLA nanoparticles as highly efficient intracellular markers for visualization of mesenchymal stromal cells by MRI

Contrast media and molecular imaging, 2014-03, Vol.9 (2), p.109-121

2014

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas

Bone marrow transplantation (Basingstoke), 2016-05, Vol.51 (5), p.654-662

2016

Volltextzugriff (PDF)

International Forum on GMP‐grade human platelet lysate for cell propagation

Vox sanguinis, 2018-01, Vol.113 (1), p.e1-e25

2018

Volltextzugriff (PDF)

Paroxysmal nocturnal haemoglobinuria treatment with eculizumab is associated with a positive direct antiglobulin test

Vox sanguinis, 2012-02, Vol.102 (2), p.159-166

2012

Volltextzugriff (PDF)

P830: CROVALIMAB MAINTAINS CLINICAL BENEFIT OVER LONG‐TERM TREATMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM THE COMPOSER TRIAL OPEN‐LABEL EXTENSION

HemaSphere, 2022-06, Vol.6 (Suppl), p.724-725

2022

Volltextzugriff (PDF)

1 – 25 von 215

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(188)
Mit Volltextzugriff
(183)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(135)
Science & Technology
(130)
Life Sciences & Biomedicine
(127)
Hematology
(82)
Biological And Medical Sciences
(68)
Male
(62)
Adult
(59)
Medical Sciences
(58)
Female
(57)
Middle Aged
(48)
Adolescent
(38)
Immunology
(37)
Aged
(33)
Hematologic And Hematopoietic Diseases
(33)
Oncology
(31)
Anemia, Aplastic - Therapy
(30)
Aplastic Anemia
(22)
Bone Marrow Transplantation
(22)
Transplantation
(21)
Child
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry

Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?

Mesenchymal stem cells for clinical application

Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups

Superior physical and mental health of healthy volunteers before and five years after mobilized stem cell donation

Changing prognosis in paroxysmal nocturnal haemoglobinuria disease subcategories: an analysis of the International PNH Registry

Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation

Aplastic anemia

Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors

Resequencing of four novel alleles with nanopore technology

Supportive care in severe and very severe aplastic anemia

How much blood is needed?

ATP promotes immunosuppressive MSCs inhibiting lymphocyte proliferation and expressing indoleamine dioxygenase

GMP-adapted overexpression of CXCR4 in human mesenchymal stem cells for cardiac repair

International Forum on GMP‐grade human platelet lysate for cell propagation: summary

Alternative immunosuppression in patients failing immunosuppression with ATG who are not transplant candidates: Campath (Alemtuzumab)

Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload

Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia

Recent improvement in outcome of unrelated donor transplantation for aplastic anemia

Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapy

Iron-loaded PLLA nanoparticles as highly efficient intracellular markers for visualization of mesenchymal stromal cells by MRI

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas

International Forum on GMP‐grade human platelet lysate for cell propagation

Paroxysmal nocturnal haemoglobinuria treatment with eculizumab is associated with a positive direct antiglobulin test

P830: CROVALIMAB MAINTAINS CLINICAL BENEFIT OVER LONG‐TERM TREATMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM THE COMPOSER TRIAL OPEN‐LABEL EXTENSION

Suchergebnisse filtern